Written by The Japan Gel Stent Market has been witnessing significant growth over recent years due to several key factors, including the increasing prevalence of glaucoma, an aging population, advancements in medical technology, and the growing awareness regarding eye health. Gel stents, which are used to treat glaucoma by reducing intraocular pressure, have become a critical tool in managing the disease, particularly in patients who are unresponsive to traditional medications or surgeries. As the demand for minimally invasive surgical procedures grows, gel stents have emerged as a preferable alternative due to their efficiency and relatively lower risk of complications compared to conventional surgery. The rise in healthcare expenditure and the growing focus on improving the quality of life for patients are further driving the adoption of gel stents in the region. Additionally, the development of more advanced gel stent technologies with enhanced biocompatibility and reduced postoperative complications is also contributing to the market’s growth. Medical professionals and patients are increasingly turning to these devices due to their ability to provide long-term relief without the need for frequent interventions, making them a preferred choice for both healthcare providers and patients. Furthermore, the shift toward outpatient procedures and less invasive treatments has positively impacted the gel stent market in Japan, as they are often used in procedures that can be performed on an outpatient basis, minimizing recovery time and costs for both patients and healthcare facilities.
Our Top Trending Article